NCT00001637
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +25 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
91 public trials
17 recruiting studies
Leukemia, Myeloid trial results
NCT02955043
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +38 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
NCT02719821
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +38 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
NCT00780104
- Conditions
- AML, CML, Hematologic Diseases, +6 more
- Locations
-
- University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT01392989
- Conditions
- Anemia, Bone Marrow Diseases, Bone Marrow Transplant Failure, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00718159
- Conditions
- Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States
NCT00065143
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
NCT00038597
- Conditions
- Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
- Locations
-
- MDAnderson Cancer Center Houston, Texas, United States
Completed
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI
NCT01602952
- Conditions
- Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +13 more
- Locations
-
- Local institution Mumbai, Maharashtra, India
- Local institution Mumbai, Mazagaon, India
- Local institution Daegu, Buk-gu, South Korea
- Local institution Jeonju, Deokjin-gu, South Korea
NCT00611247
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States